110 related articles for article (PubMed ID: 11333928)
1. Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients.
Burrer R; Salmon-Ceron D; Richert S; Pancino G; Spiridon G; Haessig S; Roques V; Barre-Sinoussi F; Aubertin AM; Moog C
J Virol; 2001 Jun; 75(11):5421-4. PubMed ID: 11333928
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
[TBL] [Abstract][Full Text] [Related]
3. Serum IgA-mediated neutralization of HIV type 1.
Burnett PR; VanCott TC; Polonis VR; Redfield RR; Birx DL
J Immunol; 1994 May; 152(9):4642-8. PubMed ID: 8157978
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.
Mazzoli S; Lopalco L; Salvi A; Trabattoni D; Lo Caputo S; Semplici F; Biasin M; Bl C; Cosma A; Pastori C; Meacci F; Mazzotta F; Villa ML; Siccardi AG; Clerici M
J Infect Dis; 1999 Sep; 180(3):871-5. PubMed ID: 10438383
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing as well as non-neutralizing polyclonal immunoglobulin (Ig)G from infected patients capture HIV-1 via antibodies directed against the principal immunodominant domain of gp41.
Burrer R; Haessig-Einius S; Aubertin AM; Moog C
Virology; 2005 Mar; 333(1):102-13. PubMed ID: 15708596
[TBL] [Abstract][Full Text] [Related]
6. Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women.
Mkhize NN; Durgiah R; Ashley V; Archary D; Garrett NJ; Karim QA; Karim SS; Moore PL; Yates N; Passmore JA; Tomaras GD; Morris L
AIDS; 2016 Apr; 30(7):1005-14. PubMed ID: 26836790
[TBL] [Abstract][Full Text] [Related]
7. Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies.
Jaspan HB; Robinson JE; Amedee AM; Van Dyke RB; Garry RF
J Clin Virol; 2004 Nov; 31(3):190-7. PubMed ID: 15465411
[TBL] [Abstract][Full Text] [Related]
8. IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity.
Black KP; Fultz PN; Girard M; Jackson S
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1263-72. PubMed ID: 9339843
[TBL] [Abstract][Full Text] [Related]
9. Frequent detection of HIV- and IgG-specific IgM and IgA antibodies in HIV-positive cord-blood sera: fine analysis by western blot.
Schüpbach J; Wunderli W; Kind C; Kernen R; Baumgartner A; Tomasik Z
AIDS; 1989 Sep; 3(9):583-9. PubMed ID: 2506903
[TBL] [Abstract][Full Text] [Related]
10. HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies.
Fouda GG; Yates NL; Pollara J; Shen X; Overman GR; Mahlokozera T; Wilks AB; Kang HH; Salazar-Gonzalez JF; Salazar MG; Kalilani L; Meshnick SR; Hahn BH; Shaw GM; Lovingood RV; Denny TN; Haynes B; Letvin NL; Ferrari G; Montefiori DC; Tomaras GD; Permar SR;
J Virol; 2011 Sep; 85(18):9555-67. PubMed ID: 21734046
[TBL] [Abstract][Full Text] [Related]
11. IgA testing for diagnosis of retroviral infections in the Caribbean.
Ridel PR; Artus JC; Capron A
Bull Pan Am Health Organ; 1991; 25(3):201-6. PubMed ID: 1742565
[TBL] [Abstract][Full Text] [Related]
12. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.
McBurney SP; Young KR; Ross TM
Virology; 2007 Feb; 358(2):334-46. PubMed ID: 17011011
[TBL] [Abstract][Full Text] [Related]
13. Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors.
Bradney AP; Scheer S; Crawford JM; Buchbinder SP; Montefiori DC
J Infect Dis; 1999 May; 179(5):1264-7. PubMed ID: 10191234
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects.
Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
AIDS Res Hum Retroviruses; 1999 Oct; 15(15):1365-76. PubMed ID: 10515152
[TBL] [Abstract][Full Text] [Related]
15. Presence of HIV-1 neutralizing IgA antibodies in primary HIV-1 infected patients.
Söderlund J; Hirbod T; Goh LE; Andersson J; Broliden K
Scand J Infect Dis; 2004; 36(9):663-9. PubMed ID: 15370653
[TBL] [Abstract][Full Text] [Related]
16. Dichotomy in cross-clade reactivity and neutralization by HIV-1 sera: Implications for active and passive immunotherapy.
Cavacini LA; Duval M; Patil A; Wood C; Mayer KH; Ruprecht RM; Posner MR
J Med Virol; 2005 Jun; 76(2):146-52. PubMed ID: 15834877
[TBL] [Abstract][Full Text] [Related]
17. Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women.
Lu XS; Bélec L; Pillot J
J Infect Dis; 1993 May; 167(5):1189-92. PubMed ID: 8486953
[TBL] [Abstract][Full Text] [Related]
18. Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection.
Özkaya Şahin G; Månsson F; Palm AA; Vincic E; da Silva Z; Medstrand P; Norrgren H; Fenyö EM; Jansson M
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):470-8. PubMed ID: 23088167
[TBL] [Abstract][Full Text] [Related]
19. Short communication: Anti-HIV-1 envelope immunoglobulin Gs in blood and cervicovaginal samples of Beninese commercial sex workers.
Batraville LA; Richard J; Veillette M; Labbé AC; Alary M; Guédou F; Kaufmann DE; Poudrier J; Finzi A; Roger M
AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1145-9. PubMed ID: 25354025
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal study of plasma and salivary antibodies in HIV-1 infection.
Wu X; Jackson S
Viral Immunol; 2002; 15(2):325-35. PubMed ID: 12081015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
